| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunic, Inc. (IMUX) has 12 insiders with recent SEC Form 4 filings, including 10 buys and 8 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.72M | $20.00M | - | |
| CFO | 560.0K | $6.51M | - | |
| Other | 330.0K | $3.84M | - | |
| COO | 330.0K | $3.84M | - | |
| Other | 315.0K | $3.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2018 | Godshall Douglas Evan | Director | Sell | 69,375 | $0.35 | $24,191.06 | -100% | |
| Sep 17, 2018 | Satter Muneer A58 | Director, 10% Owner | Sell | 11,382,277 | $0.36 | $4,145,636.97 | -43.9% | |
| Sep 13, 2018 | Hasnain Faheem74 | Director | Sell | 177,443 | $0.44 | $77,678.63 | -58.2% | |
| Sep 13, 2018 | Bienaime Jean Jacques68 | Director | Sell | 20,000 | $0.47 | $9,400.00 | -30.7% | |
| Sep 12, 2018 | Cohen Cheryl77 | Director | Sell | 3,500 | $0.55 | $1,925.00 | -100% | |
| Dec 13, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 100,000 | $5.48 | $548,335.00 | +0.4% | |
| Dec 11, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 150,000 | $4.89 | $733,140.00 | +0.4% | |
| Sep 14, 2017 | Hasnain Faheem74 | Director | Buy | 59,200 | $4.19 | $247,870.40 | +48.2% | |
| Sep 14, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 130,000 | $4.01 | $521,229.00 | +0.4% | |
| Sep 13, 2017 | Bienaime Jean Jacques68 | Director | Buy | 10,000 | $4.00 | $39,969.00 | +18.1% |